Corient Capital Partners, LLC Merck & Co., Inc. Transaction History

Corient Capital Partners, LLC

$1.34 Billion
Q3 2022

A detailed history of Corient Capital Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Corient Capital Partners, LLC holds 140,938 shares of MRK stock, worth $13.9 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares

140,938

Previous 140,938 -0.0%

Holding current value

$13.9 Million

Previous $12.8 Million -0.0%

% of portfolio

0.96%

Previous 0.97%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $438,072 - $496,576	5,247 Added 3.87%	140,938 $12.8 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $454,732 - $509,726	6,186 Added 4.78%	135,691 $11.1 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $328,874 - $411,957	4,550 Added 3.64%	129,505 $9.93 Million
Q3 2021 Nov 16, 2021	BUY	$71.68 - $78.83 $843,458 - $927,592	11,767 Added 10.4%	124,955 $9.39 Million
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $1.39 Million - $1.54 Million	19,795 Added 21.2%	113,188 $8.8 Million
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $160,650 - $189,229	2,333 Added 2.56%	93,393 $7.2 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $154,090 - $171,008	2,147 Added 2.41%	91,060 $7.45 Million
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $365,387 - $414,169	4,993 Added 5.95%	88,913 $7.38 Million
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $887,151 - $1.01 Million	12,598 Added 17.66%	83,920 $6.49 Million
Q1 2020 May 06, 2020	BUY	$63.36 - $87.82 $1.1 Million - $1.53 Million	17,438 Added 32.36%	71,322 $5.49 Million
Q4 2019 Feb 04, 2020	BUY	$77.58 - $87.54 $50,427 - $56,901	650 Added 1.22%	53,884 $4.9 Million
Q3 2019 Nov 06, 2019	BUY	$76.08 - $82.93 $751,366 - $819,016	9,876 Added 22.78%	53,234 $4.48 Million
Q2 2019 Aug 08, 2019	BUY	$69.84 - $81.59 $154,276 - $180,232	2,209 Added 5.37%	43,358 $3.64 Million
Q1 2019 May 10, 2019	BUY	$69.58 - $79.36 $930,980 - $1.06 Million	13,380 Added 48.18%	41,149 $3.42 Million
Q4 2018 Feb 07, 2019	BUY	$65.24 - $75.71 $370,693 - $430,184	5,682 Added 25.73%	27,769 $2.12 Million
Q2 2018 Oct 02, 2018	BUY	$50.83 - $59.72 $164,079 - $192,776	3,228 Added 17.12%	22,087 $1.34 Million
Q1 2018 May 14, 2018	SELL	$50.96 - $59.23 $174,639 - $202,981	-3,427 Reduced 15.38%	18,859 $1.03 Million
Q4 2017 Feb 13, 2018	SELL	$51.62 - $61.64 $74,849 - $89,378	-1,450 Reduced 6.11%	22,286 $1.25 Million
Q3 2017 Nov 14, 2017	SELL	$58.67 - $63.13 $160,462 - $172,660	-2,735 Reduced 10.33%	23,736 $0
Q2 2017 Aug 14, 2017	BUY	N/A	352 Added 1.35%	26,471 $1.7 Million
Q1 2017 Aug 17, 2017	BUY	N/A	19,231 Added 279.2%	26,119 $1.66 Million
Q1 2017 Aug 14, 2017	BUY	N/A	6,888	6,888 $441,000

Others Institutions Holding MRK

# of Institutions

3,797

Shares Held

1.92B

Call Options Held

13.3M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $250B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Account

Corient Capital Partners, LLC Merck & Co., Inc. Transaction History